Background: Vitiligo is a depigmented skin disease. S100B is a damage-associated molecular pattern protein proposed as a marker of melanocyte cytotoxicity.
Aim: To detect the sensitivity of serum levels of S100B as a disease activity marker in vitiligo patients.